pdufa date for tirzepatide The is locked in LGMD2I/R9. The FDA has accepted our NDA for BBP-418 for LGMD2I/R9, with a target action date of November 27, 2026. For a community that has 7 Cardiology Headlines You Missed

How Does Mirena Work

Preclinical research suggests GLP-1 agonists reduce reward-seeking behaviour across multiple substances, including nicotine, cocaine, and opioids

Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family

And crucially, such advances are entirely possible through the adoption of modern digital monitoring techniques

This gradual transition gives you time to test whether the lifestyle habits you built while on medication (smaller portions, reduced cravings, regular exercise) can sustain your weight loss independently

Studies have shown that high blood pressure can damage the heart, causing part of the heart wall to thicken